Apelin 13: A promising biomarker for multiple sclerosis.

dc.contributor.authorAlpua, M.
dc.contributor.authorTurkel, Y.
dc.contributor.authorDag, E.
dc.contributor.authorKisa, U.
dc.date.accessioned2020-06-25T18:16:12Z
dc.date.available2020-06-25T18:16:12Z
dc.date.issued2016
dc.departmentKırıkkale Üniversitesi
dc.description32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -- SEP 14-17, 2016 -- London, ENGLAND
dc.descriptionKISA, Ucler/0000-0002-8131-6810
dc.description.abstracten_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosisen_US
dc.description.sponsorshipKirikkale UniversityKirikkale Universityen_US
dc.description.sponsorshipOur study has supported by Kirikkale University.en_US
dc.identifier.citationclosedAccessen_US
dc.identifier.endpage877en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.startpage876en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12587/6454
dc.identifier.volume22en_US
dc.identifier.wosWOS:000383267203333
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherSage Publications Ltden_US
dc.relation.ispartofMultiple Sclerosis Journal
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleApelin 13: A promising biomarker for multiple sclerosis.en_US
dc.typeConference Object

Dosyalar